| AAV | Adeno-associated virus |
| AFP | Alpha-fetoprotein |
| AKT | Protein kinase B |
| ASO | Antisense oligonucleotide |
| AUC | Area under the curve |
| CAM | Chorio-allantoic membrane |
| CAF | Cancer-associated fibroblast |
| CH | Chronic hepatitis |
| CHB | Chronic hepatitis B |
| DEN | Diethylnitrosamine |
| DFS | Disease-free survival |
| DNMT1 | DNA methyltransferase 1 (gene symbol) |
| DNA | Deoxyribonucleic acid |
| EGFR | Epidermal growth factor receptor |
| EMT | Epithelial–mesenchymal transition |
| EV | Extracellular vesicle |
| FDG-PET | Fluorodeoxyglucose positron emission tomography |
| FASN | Fatty acid synthase (gene symbol) |
| GEMM | Genetically engineered mouse model |
| G6PD | Glucose-6-phosphate dehydrogenase |
| G6PC | Glucose-6-phosphatase |
| HDAC | Histone deacetylase |
| HCC | Hepatocellular carcinoma |
| HBV | Hepatitis B virus |
| HCV | Hepatitis C virus |
| HK2 | Hexokinase 2 (gene symbol) |
| HIF-1α | Hypoxia-inducible factor 1 alpha |
| IL-6 | Interleukin-6 |
| LDHA | Lactate dehydrogenase A |
| LNA | Locked nucleic acid |
| LNP | Lipid nanoparticle |
| LP | Liposome (carrier) |
| miRNA | MicroRNA |
| mTOR | Mechanistic target of rapamycin |
| NAFLD | Non-alcoholic fatty liver disease |
| NASH | Non-alcoholic steatohepatitis |
| NP | Nanoparticle |
| ONC | Oncogenic |
| OS | Overall survival |
| OTT | Onset To treatment |
| OXPHOS | Oxidative phosphorylation |
| PAK4 | p21-activated kinase 4 |
| PBX3 | Pre-B-cell leukemia homeobox 3 |
| PD-1 | Programmed cell death protein 1 |
| PD-L1 | Programmed death-ligand 1 |
| PDK1 | Pyruvate dehydrogenase kinase 1 |
| PET | Positron emission tomography |
| PI3K | Phosphoinositide 3-kinase |
| PKM2 | Pyruvate kinase isozyme M2 |
| PPP | Pentose–phosphate pathway |
| PTEN | Phosphatase and tensin homolog |
| qRT-PCR | Quantitative reverse transcription PCR |
| RFA | Radiofrequency ablation |
| RFS | Recurrence-free survival |
| SCD1 | Stearoyl-CoA desaturase 1 |
| SMAD4 | Small mothers against decapentaplegic 4 |
| TACE | Transarterialchemoembolisation |
| TCGA | The Cancer Genome Atlas |
| TGFβR1 | Transforming growth factor β receptor 1 |
| TKIs | Tyrosine kinase inhibitors |
| TME | Tumor microenvironment |
| TNM | Tumor–node–metastasis staging |
| TS | Tumor-suppressor |
| VEGF | Vascular endothelial growth factor |
| VE-cadherin | Vascular endothelial cadherin |
| XPO1 | Exportin 1 (gene symbol) |
| YAP1 | Yes-associated protein 1 |